 Company sees positive momentum as research contributes to growing body of evidence supporting Xoft intraoperative radiotherapy IORT technology for brain cancer Company sees positive momentum as research contributes to growing body of evidence supporting Xoft intraoperative radiotherapy IORT technology for brain cancer 